Four South Africans from groups the government wants to reach with the six-monthly HIV prevention injection, lenacapavir (LEN), tell us why they chose the shot, what happened at the clinic and whether...

A new once-a-month HIV prevention pill is moving into the final stage of testing. But early South African uptake data of the six-monthly anti-HIV jab suggest the biggest breakthrough may not be a new ...

At 33, retired Constitutional Court justice Edwin Cameron thought he had, maybe, seven years left. His story traces the arc from certain death from Aids to a chronic, manageable condition at 73 — and ...

YouTube video by Bhekisisa Centre for Health Journalism

By shutting South Africa out of its overseas funding for the roll-out of the revolutionary six-monthly HIV prevention jab which could potentially end Aids, the Trump administration undercuts its own s...

The South African government says it could fill the potential gap in the number of doses it will need of the twice-yearly HIV prevention jab to end Aids by 2043 by getting a group of local pharmaceuti...

South Africa has become the first African country — and our medicines regulator the third worldwide — to register the revolutionary twice-a-year anti-HIV jab, lenacapavir (LEN). The shot could bring a...

One in ten clinics in South Africa — across 22 health districts in six provinces — will start to hand out a twice-a-year anti-HIV jab as early as February. The country’s medicines regulator, Sahpra,…

In April next year, South Africa plans to start rolling out an anti-HIV jab, taken only twice a year, that could end Aids in the country within 14 to 18 years. But is our public health system equipped...

Two Indian generic drugmakers — Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot around R692 per person per ...

The health department plans to make the twice-a-year anti-HIV jab, lenacapavir, available at more than 300 government health districts with high HIV infection rates between April 2026 and March 2028. ...

YouTube video by Bhekisisa Centre for Health Journalism

In today’s newsletter, Tanya Pampalone asks why our girls are so stressed. Sign up for our newsletter today. Think of a young woman’s world like a series of circles, each one influencing the next.  At...

As politicians, activists and researchers duke it out from labs and clinics and press conferences, those who have the most to lose from the HIV funding cuts told Bhekisisa they have been left to fend ...

It's been two decades since the denialism war was won in South Africa. Now HIV scientists and government are pitted against each other once again, with one side saying the health minister is in denial...

R6.65-billion — or $350-million. That’s how much South Africa receives in annual funding from the US government’s National Institutes of Health. If the country loses all of its NIH funding, the countr...

The health department is convinced that all US government funding for HIV and TB projects in SA will end by September 30. The department has calculated that it needs R2.82-billion to plug the gap for ...

Up to 16% of school-aged children and 4% of adults have attention deficit and hyperactivity disorder, or ADHD, show international studies. But in South Africa, the proportion of people with ADHD who u...

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and four million HIV-negative people in the country would need to use the jab ...

A leaked memo for grant management staff of the US government’s National Institutes of Health (NIH), dated March 25, instructs officers to hold “all [research] awards to entities located in South Afri...

Cancellation letters, which end millions of rands of South African universities’ US-government funded HIV and TB research grants with immediate effect, started to roll in over the weekend. Fears are r...

Cancellation letters, which end millions of rands of South African universities’ US-government funded HIV and TB research grants with immediate effect, started to roll in over the weekend. Fears are r...

Dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding.

LAUNCH

There were empty seats in San Francisco last week at an annual international science conference which has delivered some of the world’s most groundbreaking HIV research. It was a throwback to another ...